The use of intravenous buprenorphine for the treatment of opioid withdrawal in medically ill hospitalized patients

Christopher J. Welsh; Meenakshi Suman; Art Cohen; Lauren Broyles; Melanie Bennett; Eric Weintraub

doi:10.1080/105500490290087901

The use of intravenous buprenorphine for the treatment of opioid withdrawal in medically ill hospitalized patients

Christopher J. Welsh, Meenakshi Suman, Art Cohen, Lauren Broyles, Melanie Bennett, Eric Weintraub

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

The aim of this study was to assess the safety of buprenorphine administered intravenously for the treatment of opioid withdrawal in medically ill hospitalized patients. Data regarding, demographic information, number of doses of buprenorphine, and measures of buprenorphine's effects were collected via chart reviews for 30 heroin-patients who received buprenorphine intravenously during their hospitalization for an acute medical problem. No respiratory depression was observed, and no patients reported feeling "high." All patients reported that buprenorphine decreased withdrawal symtoms. Thus, intravenous administration of buprenorphine appears to be safe for the treatment of opioid withdrawal.

Original language	English (US)
Pages (from-to)	135-140
Number of pages	6
Journal	American Journal on Addictions
Volume	11
Issue number	2
DOIs	https://doi.org/10.1080/105500490290087901
State	Published - 2002
Externally published	Yes

ASJC Scopus subject areas

Medicine (miscellaneous)
Clinical Psychology
Psychiatry and Mental health

Access to Document

10.1080/105500490290087901

Cite this

@article{8a51b4e03609478caf592eaf4a0a613d,

title = "The use of intravenous buprenorphine for the treatment of opioid withdrawal in medically ill hospitalized patients",

abstract = "The aim of this study was to assess the safety of buprenorphine administered intravenously for the treatment of opioid withdrawal in medically ill hospitalized patients. Data regarding, demographic information, number of doses of buprenorphine, and measures of buprenorphine's effects were collected via chart reviews for 30 heroin-patients who received buprenorphine intravenously during their hospitalization for an acute medical problem. No respiratory depression was observed, and no patients reported feeling {"}high.{"} All patients reported that buprenorphine decreased withdrawal symtoms. Thus, intravenous administration of buprenorphine appears to be safe for the treatment of opioid withdrawal.",

author = "Welsh, {Christopher J.} and Meenakshi Suman and Art Cohen and Lauren Broyles and Melanie Bennett and Eric Weintraub",

year = "2002",

doi = "10.1080/105500490290087901",

language = "English (US)",

volume = "11",

pages = "135--140",

journal = "American Journal on Addictions",

issn = "1055-0496",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - The use of intravenous buprenorphine for the treatment of opioid withdrawal in medically ill hospitalized patients

AU - Welsh, Christopher J.

AU - Suman, Meenakshi

AU - Cohen, Art

AU - Broyles, Lauren

AU - Bennett, Melanie

AU - Weintraub, Eric

PY - 2002

Y1 - 2002

N2 - The aim of this study was to assess the safety of buprenorphine administered intravenously for the treatment of opioid withdrawal in medically ill hospitalized patients. Data regarding, demographic information, number of doses of buprenorphine, and measures of buprenorphine's effects were collected via chart reviews for 30 heroin-patients who received buprenorphine intravenously during their hospitalization for an acute medical problem. No respiratory depression was observed, and no patients reported feeling "high." All patients reported that buprenorphine decreased withdrawal symtoms. Thus, intravenous administration of buprenorphine appears to be safe for the treatment of opioid withdrawal.

AB - The aim of this study was to assess the safety of buprenorphine administered intravenously for the treatment of opioid withdrawal in medically ill hospitalized patients. Data regarding, demographic information, number of doses of buprenorphine, and measures of buprenorphine's effects were collected via chart reviews for 30 heroin-patients who received buprenorphine intravenously during their hospitalization for an acute medical problem. No respiratory depression was observed, and no patients reported feeling "high." All patients reported that buprenorphine decreased withdrawal symtoms. Thus, intravenous administration of buprenorphine appears to be safe for the treatment of opioid withdrawal.

UR - http://www.scopus.com/inward/record.url?scp=0036106430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036106430&partnerID=8YFLogxK

U2 - 10.1080/105500490290087901

DO - 10.1080/105500490290087901

M3 - Article

C2 - 12028743

AN - SCOPUS:0036106430

SN - 1055-0496

VL - 11

SP - 135

EP - 140

JO - American Journal on Addictions

JF - American Journal on Addictions

IS - 2

ER -

The use of intravenous buprenorphine for the treatment of opioid withdrawal in medically ill hospitalized patients

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this